Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, Shandong, China.
School of Life Sciences, Dezhou University, Dezhou 253023, Shandong, China.
Curr Top Med Chem. 2021;21(5):377-403. doi: 10.2174/1568026620666200908162311.
Indole, a heterocyclic organic compound, is one of the most promising heterocycles found in natural and synthetic sources since its derivatives possess fascinating structural diversity and various therapeutic properties. Indole alkaloids, synthetic dimers and hybrids could act on diverse targets in cancer cells, and consequently, possess potential antiproliferative effects on various cancers both in vitro and in vivo. Vinblastine, midostaurin, and anlotinib as the representative of indole alkaloids, synthetic dimers and hybrids respectively, have already been clinically applied to treat many types of cancers, demonstrating indole alkaloids, synthetic dimers and hybrids are useful scaffolds for the development of novel anticancer agents. Covering articles published between 2010 and 2020, this review emphasizes the recent development of indole alkaloids, synthetic dimers and hybrids with potential in vivo therapeutic application for cancers.
吲哚,一种杂环有机化合物,是天然和合成来源中最有前途的杂环之一,因为其衍生物具有迷人的结构多样性和各种治疗特性。吲哚生物碱、合成二聚体和杂合体能作用于癌细胞中的多种靶点,因此在体外和体内对多种癌症都具有潜在的抗增殖作用。长春碱、米哚妥林和安罗替尼分别作为吲哚生物碱、合成二聚体和杂合体的代表,已经在临床上用于治疗多种癌症,表明吲哚生物碱、合成二聚体和杂合体是开发新型抗癌药物的有用支架。本综述涵盖了 2010 年至 2020 年期间发表的文章,强调了具有体内治疗应用潜力的吲哚生物碱、合成二聚体和杂合体的最新进展。